Gov. Ron DeSantis signed Florida's prescription drug importation program into law last week at The Villages, a large retirement community outside Orlando. Florida Governor's Press Office hide caption
cancer drugs cancer drugs
Stories About
cancer drugs
A recent analysis by the Kaiser Family Foundation finds that Medicare recipients taking Revlimid for cancer could end up paying, on average, $11,538 out of pocket for the drug in 2016, even if the medicine is covered by their Medicare Part D plan. Carmine Galasso/MCT/Landov hide caption
Game-changing miracle cure? Probably not. Andrew Brookes/Rafe Swan/cultura/Corbis hide caption
For best quality of life, many cancer patients who can't be cured might do best to forgo chemo and focus instead on pain relief and easing sleep and mood problems, a survey of caregivers suggests. iStockphoto hide caption
Retired California school teacher Mikkel Lawrence sits with his cat, Max. Lawrence has hepatitis C and has struggled to afford the medicine he needs to treat it. April Dembosky/KQED hide caption
A look inside the factory in Kundl, Austria, where Sandoz, a unit of Novartis, makes biosimilar drugs. Novartis hide caption
FDA Decision Signals New Competition For Some Of The Costliest Drugs
Reid Kennedy, materials manager at San Francisco General Hospital, stands next to racks of saline solution. He has had to carefully manage the hospital's supply of saline during this shortage. Mark Andrew Boyer/KQED hide caption
Don Wright runs at an indoor track at the Maplewood Community Center in North Saint Paul, Minn. Ariana Lindquist for NPR hide caption
A pharmacy buyer at the University of Utah Hospital in Salt Lake City holds a tray of magnesium sulfate, a drug in short supply.
Jim Urquhart/AP hide caption